Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Talis Biomedical Corporation (TLIS)

0.54   0.014 (2.6%) 03-22 15:18
Open: 0.55 Pre. Close: 0.5263
High: 0.55 Low: 0.53
Volume: 15,858 Market Cap: 14(M)

Technical analysis

as of: 2023-03-22 2:51:29 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 0.69     One year: 0.74
Support: Support1: 0.51    Support2: 0.43
Resistance: Resistance1: 0.59    Resistance2: 0.63
Pivot: 0.56
Moving Average: MA(5): 0.53     MA(20): 0.56
MA(100): 0.56     MA(250): 0.78
MACD: MACD(12,26): -0.1     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 10.9     %D(3): 8
RSI: RSI(14): 42.2
52-week: High: 1.58  Low: 0.42
Average Vol(K): 3-Month: 116 (K)  10-Days: 59 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ TLIS ] has closed above bottom band by 26.8%. Bollinger Bands are 20.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.54 - 0.54 0.54 - 0.55
Low: 0.51 - 0.52 0.52 - 0.52
Close: 0.52 - 0.53 0.53 - 0.53

Company Description

Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. In addition, it develops Talis One assay kit for respiratory infections, infections related to women's health, and sexually transmitted infections; and other tests for the detection of other respiratory infections, such as a respiratory panel test to detect influenza A, influenza B, and respiratory syncytial virus. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Menlo Park, California.

Headline News

Tue, 21 Mar 2023
North American Morning Briefing : Stock Futures -2- -

Thu, 03 Nov 2022
Talis Biomedical Reports Third Quarter 2022 Financial Results - GlobeNewswire

Tue, 16 Aug 2022
We're A Little Worried About Talis Biomedical's (NASDAQ:TLIS) Cash Burn Rate - Simply Wall St

Thu, 17 Mar 2022
Talis Biomedical Aims For Manufacturing Turnaround (NASDAQ:TLIS) - Seeking Alpha

Thu, 10 Feb 2022
TLIS LAWSUIT ALERT: Levi & Korsinsky Notifies Talis Biomedical Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - WTVG

Sat, 08 Jan 2022

Financial Analysis

Price to Book Value: Neutral
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Neutral
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 0 (M)
Shares Float 27 (M)
% Held by Insiders 1.418e+007 (%)
% Held by Institutions 10.1 (%)
Shares Short 235 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -1.0934e+008
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -2
Return on Assets (ttm) 134.6
Return on Equity (ttm) -29.1
Qtrly Rev. Growth 5.41e+006
Gross Profit (p.s.) 232.54
Sales Per Share -48.96
EBITDA (p.s.) -1.31053e+008
Qtrly Earnings Growth -13.8
Operating Cash Flow 0 (M)
Levered Free Cash Flow -127 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.02
Price to Cash Flow 0

Stock Dividends

Dividend 0
Forward Dividend 234790
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.